Michael Secora
Insider
First SEC filing: April 15, 2021 · Latest: April 15, 2021
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 15, 2024 | RXRX | F | 11,937 | $6.18 | $73,771 | 1,487,694 Direct | -0.80% | Disposed | -33.3% (price as of 2026-10-02) |
| Nov. 13, 2024 | RXRX | M 10b5-1 | 39,375 | $2.22 | $87,412 | 1,514,631 Direct | +2.67% | Acquired | 85.6% (price as of 2026-10-02) |
| Nov. 13, 2024 | RXRX | S 10b5-1 | 15,000 | $7.66 | $114,900 | 1,499,631 Direct | -0.99% | Disposed | -46.2% (price as of 2026-10-02) |
| Nov. 13, 2024 | RXRX | M 10b5-1 | 39,375 | · | · | 337,635 Direct | -10.44% | Disposed | (price as of 2026-10-02) |
| Nov. 12, 2024 | RXRX | M 10b5-1 | 39,375 | $2.22 | $87,412 | 1,490,256 Direct | +2.71% | Acquired | 85.6% (price as of 2026-10-02) |
| Nov. 12, 2024 | RXRX | S 10b5-1 | 15,000 | $7.64 | $114,600 | 1,475,256 Direct | -1.01% | Disposed | -46.1% (price as of 2026-10-02) |
| Nov. 12, 2024 | RXRX | M 10b5-1 | 39,375 | · | · | 377,010 Direct | -9.46% | Disposed | (price as of 2026-10-02) |
| Oct. 9, 2024 | RXRX | M 10b5-1 | 39,375 | $2.22 | $87,412 | 1,465,881 Direct | +2.76% | Acquired | 85.6% (price as of 2026-10-02) |
| Oct. 9, 2024 | RXRX | S 10b5-1 | 15,000 | $6.36 | $95,400 | 1,450,881 Direct | -1.02% | Disposed | -35.2% (price as of 2026-10-02) |
| Oct. 9, 2024 | RXRX | M 10b5-1 | 39,375 | · | · | 416,385 Direct | -8.64% | Disposed | (price as of 2026-10-02) |
| Oct. 8, 2024 | RXRX | M 10b5-1 | 39,375 | $2.22 | $87,412 | 1,441,506 Direct | +2.81% | Acquired | 85.6% (price as of 2026-10-02) |
| Oct. 8, 2024 | RXRX | S 10b5-1 | 15,000 | $6.32 | $94,800 | 1,426,506 Direct | -1.04% | Disposed | -34.8% (price as of 2026-10-02) |
| Oct. 8, 2024 | RXRX | M 10b5-1 | 39,375 | · | · | 455,760 Direct | -7.95% | Disposed | (price as of 2026-10-02) |
| Sept. 11, 2024 | RXRX | M 10b5-1 | 39,375 | $2.22 | $87,412 | 1,417,131 Direct | +2.86% | Acquired | 85.6% (price as of 2026-10-02) |
| Sept. 11, 2024 | RXRX | S 10b5-1 | 15,000 | $6.32 | $94,800 | 1,402,131 Direct | -1.06% | Disposed | -34.8% (price as of 2026-10-02) |
| Sept. 11, 2024 | RXRX | M 10b5-1 | 39,375 | · | · | 495,135 Direct | -7.37% | Disposed | (price as of 2026-10-02) |
| Sept. 10, 2024 | RXRX | M 10b5-1 | 39,375 | $2.22 | $87,412 | 1,392,756 Direct | +2.91% | Acquired | 85.6% (price as of 2026-10-02) |
| Sept. 10, 2024 | RXRX | S 10b5-1 | 15,000 | $6.17 | $92,550 | 1,377,756 Direct | -1.08% | Disposed | -33.2% (price as of 2026-10-02) |
| Sept. 10, 2024 | RXRX | M 10b5-1 | 39,375 | · | · | 534,510 Direct | -6.86% | Disposed | (price as of 2026-10-02) |
| Aug. 15, 2024 | RXRX | F | 11,962 | $6.69 | $80,026 | 1,353,381 Direct | -0.88% | Disposed | -38.4% (price as of 2026-10-02) |
| Aug. 14, 2024 | RXRX | M 10b5-1 | 39,375 | $2.22 | $87,412 | 1,380,343 Direct | +2.94% | Acquired | 85.6% (price as of 2026-10-02) |
| Aug. 14, 2024 | RXRX | S 10b5-1 | 15,000 | $6.35 | $95,250 | 1,365,343 Direct | -1.09% | Disposed | -35.1% (price as of 2026-10-02) |
| Aug. 14, 2024 | RXRX | M 10b5-1 | 39,375 | · | · | 573,885 Direct | -6.42% | Disposed | (price as of 2026-10-02) |
| Aug. 13, 2024 | RXRX | M 10b5-1 | 39,375 | $2.22 | $87,412 | 1,355,968 Direct | +2.99% | Acquired | 85.6% (price as of 2026-10-02) |
| Aug. 13, 2024 | RXRX | S 10b5-1 | 15,000 | $6.35 | $95,250 | 1,340,968 Direct | -1.11% | Disposed | -35.1% (price as of 2026-10-02) |
| Aug. 13, 2024 | RXRX | M 10b5-1 | 39,375 | · | · | 613,260 Direct | -6.03% | Disposed | (price as of 2026-10-02) |
| July 10, 2024 | RXRX | M 10b5-1 | 39,375 | $2.22 | $87,412 | 1,331,593 Direct | +3.05% | Acquired | 85.6% (price as of 2026-10-02) |
| July 10, 2024 | RXRX | S 10b5-1 | 15,000 | $7.24 | $108,600 | 1,316,593 Direct | -1.13% | Disposed | -43.1% (price as of 2026-10-02) |
| July 10, 2024 | RXRX | M 10b5-1 | 39,375 | · | · | 652,635 Direct | -5.69% | Disposed | (price as of 2026-10-02) |
| July 9, 2024 | RXRX | M 10b5-1 | 39,375 | $2.22 | $87,412 | 1,307,218 Direct | +3.11% | Acquired | 85.6% (price as of 2026-10-02) |
| July 9, 2024 | RXRX | S 10b5-1 | 15,000 | $7.32 | $109,800 | 1,292,218 Direct | -1.15% | Disposed | -43.7% (price as of 2026-10-02) |
| July 9, 2024 | RXRX | M 10b5-1 | 39,375 | · | · | 692,010 Direct | -5.38% | Disposed | (price as of 2026-10-02) |
| June 14, 2024 | RXRX | M 10b5-1 | 39,375 | $2.22 | $87,412 | 1,282,843 Direct | +3.17% | Acquired | 85.6% (price as of 2026-10-02) |
| June 14, 2024 | RXRX | S 10b5-1 | 15,000 | $9.27 | $139,050 | 1,267,843 Direct | -1.17% | Disposed | -55.6% (price as of 2026-10-02) |
| June 14, 2024 | RXRX | M 10b5-1 | 39,375 | · | · | 731,385 Direct | -5.11% | Disposed | (price as of 2026-10-02) |
| June 13, 2024 | RXRX | M 10b5-1 | 39,375 | $2.22 | $87,412 | 1,258,468 Direct | +3.23% | Acquired | 85.6% (price as of 2026-10-02) |
| June 13, 2024 | RXRX | S 10b5-1 | 15,000 | $9.32 | $139,800 | 1,243,468 Direct | -1.19% | Disposed | -55.8% (price as of 2026-10-02) |
| June 13, 2024 | RXRX | M 10b5-1 | 39,375 | · | · | 770,760 Direct | -4.86% | Disposed | (price as of 2026-10-02) |
| May 15, 2024 | RXRX | F | 11,962 | $10.01 | $119,740 | 1,219,093 Direct | -0.97% | Disposed | -58.8% (price as of 2026-10-02) |
| April 17, 2024 | RXRX | M 10b5-1 | 37,500 | $2.22 | $83,250 | 1,254,179 Direct | +3.08% | Acquired | 85.6% (price as of 2026-10-02) |
| April 17, 2024 | RXRX | S 10b5-1 | 23,124 | $7.58 | $175,280 | 1,231,055 Direct | -1.84% | Disposed | -45.6% (price as of 2026-10-02) |
| April 17, 2024 | RXRX | M | 37,500 | · | · | 810,135 Direct | -4.42% | Disposed | (price as of 2026-10-02) |
| April 16, 2024 | RXRX | M 10b5-1 | 37,500 | $2.22 | $83,250 | 1,241,679 Direct | +3.11% | Acquired | 85.6% (price as of 2026-10-02) |
| April 16, 2024 | RXRX | S 10b5-1 | 25,000 | $7.67 | $191,750 | 1,216,679 Direct | -2.01% | Disposed | -46.3% (price as of 2026-10-02) |
| April 16, 2024 | RXRX | M | 37,500 | · | · | 847,635 Direct | -4.24% | Disposed | (price as of 2026-10-02) |
| March 13, 2024 | RXRX | M 10b5-1 | 37,500 | $2.22 | $83,250 | 1,229,179 Direct | +3.15% | Acquired | 85.6% (price as of 2026-10-02) |
| March 13, 2024 | RXRX | S 10b5-1 | 25,000 | $11.03 | $275,750 | 1,204,179 Direct | -2.03% | Disposed | -62.6% (price as of 2026-10-02) |
| March 13, 2024 | RXRX | M 10b5-1 | 37,500 | · | · | 885,135 Direct | -4.06% | Disposed | (price as of 2026-10-02) |
| March 12, 2024 | RXRX | M 10b5-1 | 37,500 | $2.22 | $83,250 | 1,216,679 Direct | +3.18% | Acquired | 85.6% (price as of 2026-10-02) |
| March 12, 2024 | RXRX | S 10b5-1 | 25,000 | $10.46 | $261,500 | 1,191,679 Direct | -2.05% | Disposed | -60.6% (price as of 2026-10-02) |
| March 12, 2024 | RXRX | M 10b5-1 | 37,500 | · | · | 922,635 Direct | -3.91% | Disposed | (price as of 2026-10-02) |
| Feb. 15, 2024 | RXRX | F | 7,172 | $12.43 | $89,148 | 1,179,179 Direct | -0.60% | Disposed | -66.9% (price as of 2026-10-02) |
| Feb. 14, 2024 | RXRX | M 10b5-1 | 37,500 | · | · | 960,135 Direct | -3.76% | Disposed | (price as of 2026-10-02) |
| Feb. 14, 2024 | RXRX | S 10b5-1 | 1,067 | $10.98 | $11,716 | 1,186,351 Direct | -0.09% | Disposed | -62.5% (price as of 2026-10-02) |
| Feb. 14, 2024 | RXRX | S 10b5-1 | 23,933 | $10.43 | $249,621 | 1,187,418 Direct | -1.98% | Disposed | -60.5% (price as of 2026-10-02) |
| Feb. 14, 2024 | RXRX | M 10b5-1 | 37,500 | $2.22 | $83,250 | 1,211,351 Direct | +3.19% | Acquired | 85.6% (price as of 2026-10-02) |
| Feb. 13, 2024 | RXRX | M 10b5-1 | 37,500 | · | · | 997,635 Direct | -3.62% | Disposed | (price as of 2026-10-02) |
| Feb. 13, 2024 | RXRX | S 10b5-1 | 25,000 | $9.86 | $246,500 | 1,173,851 Direct | -2.09% | Disposed | -58.2% (price as of 2026-10-02) |
| Feb. 13, 2024 | RXRX | M 10b5-1 | 37,500 | $2.22 | $83,250 | 1,198,851 Direct | +3.23% | Acquired | 85.6% (price as of 2026-10-02) |
| Feb. 9, 2024 | RXRX | A | 348,380 | · | · | 348,380 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 9, 2024 | RXRX | F | 2,512 | $10.09 | $25,346 | 1,161,351 Direct | -0.22% | Disposed | -59.2% (price as of 2026-10-02) |
| Feb. 9, 2024 | RXRX | A | 174,190 | · | · | 1,163,863 Direct | +17.60% | Acquired | (price as of 2026-10-02) |
| Feb. 9, 2024 | RXRX | A | 8,659 | · | · | 989,673 Direct | +0.88% | Acquired | (price as of 2026-10-02) |
| Jan. 17, 2024 | RXRX | M 10b5-1 | 37,500 | · | · | 1,035,135 Direct | -3.50% | Disposed | (price as of 2026-10-02) |
| Jan. 17, 2024 | RXRX | S 10b5-1 | 25,000 | $10.25 | $256,250 | 981,014 Direct | -2.49% | Disposed | -59.8% (price as of 2026-10-02) |
| Jan. 17, 2024 | RXRX | M 10b5-1 | 37,500 | $2.22 | $83,250 | 1,006,014 Direct | +3.87% | Acquired | 85.6% (price as of 2026-10-02) |
| Jan. 16, 2024 | RXRX | M 10b5-1 | 37,500 | · | · | 1,072,635 Direct | -3.38% | Disposed | (price as of 2026-10-02) |
| Jan. 16, 2024 | RXRX | S 10b5-1 | 25,000 | $10.45 | $261,250 | 968,514 Direct | -2.52% | Disposed | -60.6% (price as of 2026-10-02) |
| Jan. 16, 2024 | RXRX | M 10b5-1 | 37,500 | $2.22 | $83,250 | 993,514 Direct | +3.92% | Acquired | 85.6% (price as of 2026-10-02) |
| Dec. 13, 2023 | RXRX | M 10b5-1 | 37,500 | · | · | 1,110,135 Direct | -3.27% | Disposed | (price as of 2026-10-02) |
| Dec. 13, 2023 | RXRX | S 10b5-1 | 25,000 | $7.59 | $189,750 | 956,014 Direct | -2.55% | Disposed | -45.7% (price as of 2026-10-02) |
| Dec. 13, 2023 | RXRX | M 10b5-1 | 37,500 | $2.22 | $83,250 | 981,014 Direct | +3.97% | Acquired | 85.6% (price as of 2026-10-02) |
| Dec. 12, 2023 | RXRX | M 10b5-1 | 37,500 | · | · | 1,147,635 Direct | -3.16% | Disposed | (price as of 2026-10-02) |
| Dec. 12, 2023 | RXRX | S 10b5-1 | 25,000 | $7.39 | $184,750 | 943,514 Direct | -2.58% | Disposed | -44.2% (price as of 2026-10-02) |
| Dec. 12, 2023 | RXRX | M 10b5-1 | 37,500 | $2.22 | $83,250 | 968,514 Direct | +4.03% | Acquired | 85.6% (price as of 2026-10-02) |
| Nov. 15, 2023 | RXRX | M 10b5-1 | 37,500 | · | · | 1,185,135 Direct | -3.07% | Disposed | (price as of 2026-10-02) |
| Nov. 15, 2023 | RXRX | F | 7,172 | $7.18 | $51,495 | 931,014 Direct | -0.76% | Disposed | -42.6% (price as of 2026-10-02) |
| Nov. 15, 2023 | RXRX | S 10b5-1 | 4,700 | $7.62 | $35,814 | 938,186 Direct | -0.50% | Disposed | -45.9% (price as of 2026-10-02) |
| Nov. 15, 2023 | RXRX | S 10b5-1 | 20,300 | $7.25 | $147,175 | 942,886 Direct | -2.11% | Disposed | -43.2% (price as of 2026-10-02) |
| Nov. 15, 2023 | RXRX | M 10b5-1 | 37,500 | $2.22 | $83,250 | 963,186 Direct | +4.05% | Acquired | 85.6% (price as of 2026-10-02) |
| Nov. 14, 2023 | RXRX | M 10b5-1 | 37,500 | · | · | 1,222,635 Direct | -2.98% | Disposed | (price as of 2026-10-02) |
| Nov. 14, 2023 | RXRX | S 10b5-1 | 25,000 | $6.32 | $158,000 | 925,686 Direct | -2.63% | Disposed | -34.8% (price as of 2026-10-02) |
| Nov. 14, 2023 | RXRX | M 10b5-1 | 37,500 | $2.22 | $83,250 | 950,686 Direct | +4.11% | Acquired | 85.6% (price as of 2026-10-02) |
| Oct. 11, 2023 | RXRX | M 10b5-1 | 37,500 | · | · | 1,260,135 Direct | -2.89% | Disposed | (price as of 2026-10-02) |
| Oct. 11, 2023 | RXRX | S 10b5-1 | 25,000 | $6.85 | $171,250 | 913,186 Direct | -2.66% | Disposed | -39.9% (price as of 2026-10-02) |
| Oct. 11, 2023 | RXRX | M 10b5-1 | 37,500 | $2.22 | $83,250 | 938,186 Direct | +4.16% | Acquired | 85.6% (price as of 2026-10-02) |
| Oct. 10, 2023 | RXRX | M 10b5-1 | 37,500 | · | · | 1,297,635 Direct | -2.81% | Disposed | (price as of 2026-10-02) |
| Oct. 10, 2023 | RXRX | S 10b5-1 | 25,000 | $7.07 | $176,750 | 900,686 Direct | -2.70% | Disposed | -41.7% (price as of 2026-10-02) |
| Oct. 10, 2023 | RXRX | M 10b5-1 | 37,500 | $2.22 | $83,250 | 925,686 Direct | +4.22% | Acquired | 85.6% (price as of 2026-10-02) |
| Sept. 13, 2023 | RXRX | M 10b5-1 | 37,500 | · | · | 1,335,135 Direct | -2.73% | Disposed | (price as of 2026-10-02) |
| Sept. 13, 2023 | RXRX | S 10b5-1 | 25,000 | $8.69 | $217,250 | 888,186 Direct | -2.74% | Disposed | -52.6% (price as of 2026-10-02) |
| Sept. 13, 2023 | RXRX | M 10b5-1 | 37,500 | $2.22 | $83,250 | 913,186 Direct | +4.28% | Acquired | 85.6% (price as of 2026-10-02) |
| Sept. 12, 2023 | RXRX | M 10b5-1 | 37,500 | · | · | 1,372,635 Direct | -2.66% | Disposed | (price as of 2026-10-02) |
| Sept. 12, 2023 | RXRX | S 10b5-1 | 25,000 | $8.43 | $210,750 | 875,686 Direct | -2.78% | Disposed | -51.1% (price as of 2026-10-02) |
| Sept. 12, 2023 | RXRX | M 10b5-1 | 37,500 | $2.22 | $83,250 | 900,686 Direct | +4.34% | Acquired | 85.6% (price as of 2026-10-02) |
| Aug. 16, 2023 | RXRX | M 10b5-1 | 37,500 | · | · | 1,410,135 Direct | -2.59% | Disposed | (price as of 2026-10-02) |
| Aug. 16, 2023 | RXRX | S 10b5-1 | 25,000 | $8.90 | $222,500 | 863,186 Direct | -2.81% | Disposed | -53.7% (price as of 2026-10-02) |
| Aug. 16, 2023 | RXRX | M 10b5-1 | 37,500 | $2.22 | $83,250 | 888,186 Direct | +4.41% | Acquired | 85.6% (price as of 2026-10-02) |
| Aug. 15, 2023 | RXRX | M 10b5-1 | 37,500 | · | · | 1,485,135 Direct | -2.46% | Disposed | (price as of 2026-10-02) |
| Aug. 15, 2023 | RXRX | S 10b5-1 | 25,000 | $9.27 | $231,750 | 850,686 Direct | -2.85% | Disposed | -55.6% (price as of 2026-10-02) |
Showing latest 100 of 142 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 13, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 39,375 | Disposed |
| Nov. 12, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 39,375 | Disposed |
| Oct. 9, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 39,375 | Disposed |
| Oct. 8, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 39,375 | Disposed |
| Sept. 11, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 39,375 | Disposed |
| Sept. 10, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 39,375 | Disposed |
| Aug. 14, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 39,375 | Disposed |
| Aug. 13, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 39,375 | Disposed |
| July 10, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 39,375 | Disposed |
| July 9, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 39,375 | Disposed |
| June 14, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 39,375 | Disposed |
| June 13, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 39,375 | Disposed |
| April 17, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| April 16, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| March 13, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| March 12, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| Feb. 14, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| Feb. 13, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| Feb. 9, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $10.09 | Feb. 9, 2034 | 348,380 | Acquired |
| Jan. 17, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| Jan. 16, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| Dec. 13, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| Dec. 12, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| Nov. 15, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| Nov. 14, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| Oct. 11, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| Oct. 10, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| Sept. 13, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| Sept. 12, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| Aug. 16, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| Aug. 15, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| July 19, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| July 18, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| June 14, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| June 13, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $2.22 | March 3, 2030 | 37,500 | Disposed |
| Feb. 1, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $8.55 | Feb. 1, 2033 | 404,857 | Acquired |
| Feb. 4, 2022 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $11.40 | Feb. 4, 2032 | 3,914 | Acquired |
| Feb. 4, 2022 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $11.40 | Feb. 4, 2032 | 116,684 | Acquired |
| April 20, 2021 | RXRX | Stock Option (Right to Buy) | Class A Common Stock [F1] | $2.22 | March 30, 2030 | 1,500,000 | Acquired |
| April 20, 2021 | RXRX | Stock Option (Right to Buy) | Class A Common Stock [F1] | $2.22 | March 30, 2030 | 820,313 | Acquired |
| April 20, 2021 | RXRX | Stock Option (Right to Buy) | Common Stock [F1] | $2.22 | March 30, 2030 | 1,500,000 | Disposed |
| April 20, 2021 | RXRX | Stock Option (Right to Buy) | Common Stock [F1] | $2.22 | March 30, 2030 | 820,313 | Disposed |
| April 20, 2021 | RXRX | Series D Preferred Stock | Common Stock [F1] | · | · | 149,077 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $475,000 | · | $1,757,577 | $2,233,116 | · | · | $577,813 | $5,043,506 |
| 2023 | $435,583 | · | $1,730,759 | $2,153,839 | $174,369 | · | $19,830 | $4,514,381 |
| 2020 | $170,833 | $63,000 | · | $3,431,798 | $15,357 | · | $37,500 | $3,718,488 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.